4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000056
CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $78.98 ($1,184,767)
- CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-08-23 | Option exercise 10b5-1 | +15,000 | $2.03 | $30,450 | 493,888 | D: show line 1 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-08-23 | Sale 10b5-1 | −6,686 | $78.65 | $525,861 | 487,202 | D: show line 2 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-08-23 | Sale 10b5-1 | −8,314 | $79.25 | $658,906 | 478,888 | D: show line 3 in the form |
| Open-market sales · 15,000 sh · avg $78.98 · $1,184,767 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-08-23 | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 167,327 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1724705892.xml…